Angion Biomedica Corp (ANGN) Social Stream



Angion Biomedica Corp (ANGN): $10.00

0.20 (+2.04%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add ANGN to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#70 of 437

in industry

ANGION BIOMEDICA CORP (ANGN) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering ANGION BIOMEDICA CORP.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 4 $50 $15 $26.666 $1 2566.6%
2022-03-30 3 $50 $5 $21 $1 2000%
2022-04-01 4 $50 $5 $21 $1 2000%
2022-05-16 4 $32 $5 $15 $1 1400%
2022-05-23 4 $28 $5 $13.666 $1 1266.6%
2022-06-30 4 $1.5 $1.5 $1.5 $1 50%
2022-08-15 3 $1.5 $1.5 $1.5 $1 50%
NA 2 $NA $NA $NA $1 NA%

The Trend in the Analyst Price Target


Over the past 35 weeks, ANGN's average price target has gone down $19.5.

ANGN reports an average of 35.8% for its upside potential over the past 46 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-06-30 3 1.5 1.5 1.5 1.14 31.58%
2022-06-30 4 1.5 1.5 1.5 1.14 31.58%
2022-08-15 3 1.5 1.5 1.5 1.04 44.23%

ANGN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 3 0 0 3

The Trend in the Broker Recommendations


ANGN's average broker recommendation rating worsened by 2 over the prior 153 days.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how ANGION BIOMEDICA CORP fares relative to all US stocks, note that its variance in analysts' estimates is lower than -386.03% of that group.
  • In the context of all US stocks, ANGION BIOMEDICA CORP's number of analysts covering the stock is greater than 95.71% of them.
  • In terms of how ANGION BIOMEDICA CORP fares relative to stocks in the small market cap category, note that its upside potential (average analyst target price relative to current price) is higher than 546.6% of that group.
  • In terms of how ANGION BIOMEDICA CORP fares relative to Healthcare stocks, note that its average analyst price target is greater than 174.74% of that group.

In the Pharmaceutical Products industry, BOLT, TERN, and ADAG are the three stocks most similar to ANGION BIOMEDICA CORP regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding ANGN using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!